Found: 5
Select item for more details and to access through your institution.
Evaluation of a Novel Calcium Channel Agonist for Therapeutic Potential in Lambert-Eaton Myasthenic Syndrome.
- Published in:
- Journal of Neuroscience, 2013, v. 33, n. 25, p. 10559, doi. 10.1523/JNEUROSCI.4629-12.2013
- By:
- Publication type:
- Article
Lambert–Eaton myasthenic syndrome: mouse passive‐transfer model illuminates disease pathology and facilitates testing therapeutic leads.
- Published in:
- Annals of the New York Academy of Sciences, 2018, v. 1412, n. 1, p. 73, doi. 10.1111/nyas.13512
- By:
- Publication type:
- Article
New calcium channel agonists as potential therapeutics in Lambert-Eaton myasthenic syndrome and other neuromuscular diseases.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1275, n. 1, p. 85, doi. 10.1111/nyas.12001
- By:
- Publication type:
- Article
Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 6, p. 740, doi. 10.3390/biom12060740
- By:
- Publication type:
- Article
Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K<sup>+</sup> channel blocker and a Ca<sup>2+</sup> channel agonist.
- Published in:
- Journal of Physiology, 2014, v. 592, n. 16, p. 3687, doi. 10.1113/jphysiol.2014.276493
- By:
- Publication type:
- Article